A new systemic nutrition-inflammation index predicted perioperative non-small cell lung cancer outcomes better than current ...

The following is a summary of "Clinicopathologic and genomic analyses of SMARCA4-mutated non-small cell lung carcinoma ...

Microbio Co., Ltd. (TPEx: 4128) today announced promising results from an exploratory clinical trial assessing MS-20 in ...

HONG KONG, China I March 16, 2025 I Akeso Inc. (9926.HK) announced that its innovative, self-developed anti-PD-1 monoclonal antibody, penpulimab, has been ...

In the continuing evolution of personalized medicine, a new Yale study has found evidence to support the value of a tool that ...

In the continuing evolution of personalized medicine, a new Yale study has found evidence to support the value of a tool that measures the presence of ...

Approval based on ADRIATIC Phase III trial results which showed a 27% reduction in the risk of death versus placebo ...

Global Bispecific Antibodies market size to surpass US$ 50 Billion By 2030 Says Kuick Research Delhi, March 17, 2025 (GLOBE ...

The appeals court for the Federal Circuit upheld a lower court’s ruling, finding that Regeneron has not sufficiently ...

The table is a review of notable updates that occurred in February 2025 for investigational products in development.

AbbVie has pointed to a very strong launch trajectory for Elahere, with sales rocketing to $480 million last year, almost ...